CLL and Lymphomas | Fall Oncology Nursing Series: Chimeric Antigen Receptor T-Cell Therapy in Chronic Lymphocytic Leukemia and Lymphomas — Session 2

Featuring perspectives from Dr Jeremy Abramson and Ms Elizabeth Zerante, including the following topics:  Introduction (0:00) Toxicities with Chimeric Antigen Receptor (CAR) T-Cell Therapy — Grading, Management and Patient Education (10:56) Case: A woman in her early 60s with relapsed/refractory chronic lymphocytic leukemia (CLL) (36:28) Case: A woman in her early 60s with relapsed/refractory CLL/SLL (small lymphocytic lymphoma) (40:46) Case: A man in his early 80s with a history of CLL and double-hit diffuse large B-cell lymphoma (45:15) Clinical Use of CAR T-Cell Therapies for CLL and Lymphomas (55:25) CME information and select publications